Carbon nanotubes are nanometric-sized materiale which possess a set of interesting features that favor their applications in various fields of materials engineering, including biomedical applications. However, their usage as implants or in nanomedicine raises many questions, regarding their potential cytotoxicity, relative to their length, diameter, structure and functional groups, present on their outer walls. The given study presents a physiochemical and biological in vitro (in accordance with EN-ISO 10993-5) evaluation of thin carbon nanotubes films, deposited on the surface of titanium, by means of the EPD process. Experiments were carried out on commercially available, pre-functionalized with OH groups, multi-walled carbon nanotubes. The obtained material is proven to be biocompatible, with no cytotoxic effect on the human fetal osteoblast cell line. During the study, selectivity of the EPD process was proven - performed experiments revealed that the process favors deposition of CNTs with chosen set of features from the stock solution. Presented results point out that the EPD process can be successfully applied as a method for fractioning the CNTs, aimed to fabricate non-toxic layers that might be considered for various biomedical applications.